Published in Eur J Cancer on October 01, 2003
Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer (2005) 4.19
Five misconceptions in cancer diagnosis. Br J Gen Pract (2009) 2.07
Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg (2006) 1.78
The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study. BMC Med (2009) 1.76
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Estimating the incidence of colorectal cancer in Sub-Saharan Africa: A systematic analysis. J Glob Health (2012) 1.07
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis (2006) 1.06
A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open (2013) 1.00
New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells. BMC Cancer (2009) 1.00
The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ (2010) 0.96
Patterns of colorectal cancer care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr (2013) 0.93
Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules. Clin Exp Immunol (2010) 0.90
Endoscopic mucosal resection: an evolving therapeutic strategy for non-polypoid colorectal neoplasia. Gut (2004) 0.90
Preliminary results of a feasibility study of the use of information technology for identification of suspected colorectal cancer in primary care: the CREDIBLE study. Br J Cancer (2015) 0.89
Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients. J Cancer Res Clin Oncol (2013) 0.89
Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer (2012) 0.88
Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration. Int J Colorectal Dis (2006) 0.82
Level of colorectal cancer awareness: a cross sectional exploratory study among multi-ethnic rural population in Malaysia. BMC Cancer (2013) 0.80
Baseline mortality-adjusted survival in colon cancer patients. Langenbecks Arch Surg (2016) 0.79
Measuring the Effect of Improved Medical Facilities and Focused Training on Data Quality and Completeness: An Example from the Gharbiah Population-Based Cancer Registry, Egypt. J Registry Manag (2015) 0.78
Colorectal cancer screening awareness among physicians in Greece. BMC Gastroenterol (2006) 0.78
Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer. Int J Colorectal Dis (2012) 0.78
Race Matters: Analyzing the Relationship between Colorectal Cancer Mortality Rates and Various Factors within Respective Racial Groups. Front Public Health (2014) 0.77
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†. Ann Oncol (2015) 0.76
Novel colorectal endoscopic in vivo imaging and resection practice: a short practice guide for interventional endoscopists. Tech Coloproctol (2007) 0.76
Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer. Oncotarget (2017) 0.75
Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995-2004). Support Care Cancer (2009) 0.75
Colorectal Carcinomas in Uyo City, Southern Geopolitical Zone of Nigeria: A Review of Clinicopathological Characteristics and Literature. Rare Tumors (2016) 0.75
Commentary on "data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry". Ann Coloproctol (2014) 0.75
A retrospective analysis of 2000 cases with colorectal carcinoma. Tech Coloproctol (2011) 0.75
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer (2009) 5.61
Change in male:female ratio among newborn infants in Denmark. Lancet (1996) 4.85
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol (2008) 4.78
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer (2009) 4.31
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut (2001) 4.22
Cancer survival in England and Wales at the end of the 20th century. Br J Cancer (2008) 4.18
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol (2005) 4.07
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Cancer in the European Community and its member states. Eur J Cancer (1990) 3.95
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
How many deaths have been avoided through improvements in cancer survival? BMJ (2000) 3.68
Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave. J Epidemiol Community Health (1998) 3.67
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Natural variation in the human sex ratio. Hum Reprod (1999) 3.27
Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer (2009) 3.27
Trends in cancer incidence and mortality. IARC Sci Publ (1993) 3.19
Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics (1982) 3.18
A computer program package for relative survival analysis. Comput Programs Biomed (1985) 3.10
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis (1978) 3.08
The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer (1988) 3.07
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer (2006) 2.76
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
The completeness of cancer registration in follow-up studies--a cautionary note. Br J Cancer (1987) 2.66
Deprivation, stage at diagnosis and cancer survival. Int J Cancer (1995) 2.50
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Br J Cancer (2010) 2.45
Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40
Incidence of uveal melanoma in Europe. Ophthalmology (2007) 2.30
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Deprivation and survival from breast cancer. Br J Cancer (1995) 2.27
Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer (2012) 2.24
Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med (2001) 2.20
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol (2013) 2.17
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer (2009) 2.12
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) Am J Epidemiol (1995) 2.09
Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer (2009) 2.08
The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev (2005) 2.08
Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. BMJ (1994) 2.04
Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.04
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03
Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol (2005) 2.02
Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst (1985) 2.00
Decline in sex ratio at birth after Kobe earthquake. Hum Reprod (1998) 1.98
The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer (2008) 1.93
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86
Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993. Eur Heart J (1999) 1.84
Cancer registration: principles and methods. Analysis of survival. IARC Sci Publ (1991) 1.84
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer (2011) 1.84
Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med (1999) 1.82
Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer (2009) 1.81
Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health (1989) 1.81
Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England. Br J Cancer (2003) 1.80
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75
Incidence of childhood cancer in Finland. J Natl Cancer Inst (1975) 1.73
'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol (2009) 1.73
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer (2005) 1.72
Evaluation of ultrasound-estimated date of delivery in 17,450 spontaneous singleton births: do we need to modify Naegele's rule? Ultrasound Obstet Gynecol (1999) 1.71
Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer (1988) 1.69
Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer (2003) 1.69
Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer (2004) 1.68
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ (2006) 1.68
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer (2005) 1.66
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63
Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect (1998) 1.60
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60